Eli Lilly and Co
LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
IndianapolisIN46285
USAT: +1 317 276-2000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
43,000
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,415.00 | 143.60 | -1.68% |
CAC 40 | 7,266.20 | 118.42 | -1.60% |
DAX 40 | 19,987.80 | 254.77 | -1.26% |
Dow JONES (US) | 42,326.87 | 1,123.03 | -2.58% |
FTSE 100 | 8,084.40 | 114.71 | -1.40% |
HKSE | 19,752.51 | 112.04 | -0.56% |
NASDAQ | 19,392.69 | 716.37 | -3.56% |
Nikkei 225 | 38,813.58 | 268.13 | -0.69% |
NZX 50 Index | 12,754.15 | 111.40 | -0.87% |
S&P 500 | 5,872.16 | 178.45 | -2.95% |
S&P/ASX 200 | 8,168.20 | 141.20 | -1.70% |
SSE Composite Index | 3,370.03 | 12.17 | -0.36% |